250 related articles for article (PubMed ID: 29346141)
1. Caffeine controversies.
Gentle SJ; Travers CP; Carlo WA
Curr Opin Pediatr; 2018 Apr; 30(2):177-181. PubMed ID: 29346141
[TBL] [Abstract][Full Text] [Related]
2. Caffeine for apnea of prematurity.
Hand IL; Noble LM
N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
[No Abstract] [Full Text] [Related]
3. Childhood respiratory outcomes after neonatal caffeine therapy.
Cheong JLY; Doyle LW
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101158. PubMed ID: 33127315
[TBL] [Abstract][Full Text] [Related]
4. The Role of Caffeine in Noninvasive Respiratory Support.
Dobson NR; Patel RM
Clin Perinatol; 2016 Dec; 43(4):773-782. PubMed ID: 27837758
[TBL] [Abstract][Full Text] [Related]
5. Neurodevelopmental outcomes after neonatal caffeine therapy.
Synnes A; Grunau RE
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101160. PubMed ID: 33121916
[TBL] [Abstract][Full Text] [Related]
6. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based methylxanthine use in the NICU.
Spitzer AR
Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
[TBL] [Abstract][Full Text] [Related]
8. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
Rostas SE; McPherson C
Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
[TBL] [Abstract][Full Text] [Related]
9. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants.
Dobson NR; Patel RM; Smith PB; Kuehn DR; Clark J; Vyas-Read S; Herring A; Laughon MM; Carlton D; Hunt CE
J Pediatr; 2014 May; 164(5):992-998.e3. PubMed ID: 24461786
[TBL] [Abstract][Full Text] [Related]
10. Early caffeine therapy and clinical outcomes in extremely preterm infants.
Patel RM; Leong T; Carlton DP; Vyas-Read S
J Perinatol; 2013 Feb; 33(2):134-40. PubMed ID: 22538326
[TBL] [Abstract][Full Text] [Related]
11. Caffeine citrate: when and for how long. A literature review.
Picone S; Bedetta M; Paolillo P
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
[TBL] [Abstract][Full Text] [Related]
12. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
Dobson NR; Hunt CE
Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
[TBL] [Abstract][Full Text] [Related]
13. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
[TBL] [Abstract][Full Text] [Related]
14. Caffeine for apnea of prematurity.
Bancalari E
N Engl J Med; 2006 May; 354(20):2179-81. PubMed ID: 16707756
[No Abstract] [Full Text] [Related]
15. Caffeine use in the neonatal intensive care unit.
Abu-Shaweesh JM; Martin RJ
Semin Fetal Neonatal Med; 2017 Oct; 22(5):342-347. PubMed ID: 28801176
[TBL] [Abstract][Full Text] [Related]
16. Caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
Ten Hove CH; Vliegenthart RJ; Te Pas AB; Brouwer E; Rijken M; van Wassenaer-Leemhuis AG; van Kaam AH; Onland W
Neonatology; 2016; 110(1):21-6. PubMed ID: 26967910
[TBL] [Abstract][Full Text] [Related]
18. Caffeine and bronchopulmonary dysplasia: Clinical benefits and the mechanisms involved.
Yuan Y; Yang Y; Lei X; Dong W
Pediatr Pulmonol; 2022 Jun; 57(6):1392-1400. PubMed ID: 35318830
[TBL] [Abstract][Full Text] [Related]
19. Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis.
Oliphant EA; Hanning SM; McKinlay CJD; Alsweiler JM
J Perinatol; 2024 Jun; 44(6):785-801. PubMed ID: 38553606
[TBL] [Abstract][Full Text] [Related]
20. What is bronchopulmonary dysplasia and does caffeine prevent it?
Jensen EA
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101176. PubMed ID: 33168465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
